Le Lézard
Classified in: Health
Subjects: AWD, NPT

TESARO to Receive 2018 Partnership Award at CancerCare® Gala


NEW YORK, April 19, 2018 /PRNewswire-USNewswire/ -- CancerCare®, the leading national nonprofit organization providing free, professional support services to anyone affected by cancer, announced that TESARO will receive their 2018 Partnership Award. The Partnership Award recognizes the most valued and critical supporters to CancerCare's growth as a cancer service organization. The award will be presented at the CancerCare Gala, taking place on Wednesday, April 25 in New York City.

Founded in 1944, CancerCare(R) is the leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.

Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO, will accept the award on behalf of TESARO, a biopharmaceutical company devoted to providing transformative therapies to people facing cancer. TESARO has been a corporate sponsor of CancerCare since 2016, helping to raise awareness of and supporting the organization's important activities, such as counseling and support groups.

"We are grateful for TESARO's partnership with CancerCare which exemplifies our shared commitment to putting patients first," said Patricia J. Goldsmith, CEO of CancerCare. "The TESARO team's ongoing support of our focus on improving the patient experience is greatly valued and critical to our programs' success."

"Our mission at TESARO is to provide transformative therapies to people facing cancer, and we are able to do so because of our partnerships with the broader cancer community. The values of our two organizations are well-aligned, making collaboration a natural fit," said Lonnie Moulder, CEO of TESARO. "We are proud to work alongside CancerCare to support 'the whole patient' and their families ? a concept upon which TESARO was founded. Mary Lynne and I are honored to accept this award on behalf of all our associates, and we look forward to our continued partnership and shared commitment to help patients and their loved ones for years to come."

The annual CancerCare Gala honors corporations and individuals that have made substantial contributions to improving the lives of people affected by cancer through their partnerships with CancerCare. The event raises crucial funds for and increases awareness about CancerCare's free, professional support services, including counseling and support groups, educational workshops and publications, and financial and co-payment assistance. Other honorees include CancerCare members Cornelia and Rob Spring who will receive the 2018 Help & Hope Award for their work on CancerCare's National Board.

To learn more about the event, please visit https://community.cancercare.org/gala2018.

About CancerCare®
Founded in 1944, CancerCare is the leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer. Our comprehensive services include counseling and support groups over the phone, online and in-person, educational workshops, publications and financial and co-payment assistance. All CancerCare services are provided by oncology social workers and world-leading cancer experts.

To learn more, visit www.cancercare.org or call 800-813-HOPE (4673).

SOURCE CancerCare


These press releases may also interest you

at 12:22
Claudia Black, PhD, and Meadows Behavioral Healthcare are proud to announce the release of Undaunted Hope, featuring a foreword by Bessel van der Kolk, MD, author of the New York Times bestseller The Body Keeps the Score....

at 12:20
The "Elastomers: Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering. The Global Elastomers Market was valued at USD 105 Billion in 2023 and is expected to grow to USD 153.5 Billion in 2028, rising at a CAGR...

at 12:07
Getlabs, the nationwide leader in at-home diagnostics collection, has joined forces with Inocras, a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases....

at 12:06
Elegancia Healthcare W.L.L, a subsidiary of Estithmar Holding has entered into a second strategic agreement with...

at 12:05
Molecular Instruments, Inc. announced today that the Patents Court of the High Court of England and Wales has found two patents owned by Advanced Cell Diagnostics, Inc. (a Bio-Techne group company) to be invalid. In a 2022 lawsuit filed in the...

at 12:00
The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Oncology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the oncology deals...



News published on and distributed by: